These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 9114139

  • 1. Treatment of penicillin-resistant pneumococcal bacteremia in neutropenic patients with cancer.
    Carratalà J, Marron A, Fernández-Sevilla A, Liñares J, Gudiol F.
    Clin Infect Dis; 1997 Feb; 24(2):148-52. PubMed ID: 9114139
    [Abstract] [Full Text] [Related]

  • 2. Bacteremic pneumonia in neutropenic patients with cancer: causes, empirical antibiotic therapy, and outcome.
    Carratalà J, Rosón B, Fernández-Sevilla A, Alcaide F, Gudiol F.
    Arch Intern Med; 1998 Apr 27; 158(8):868-72. PubMed ID: 9570172
    [Abstract] [Full Text] [Related]

  • 3. Bacteremia due to viridans streptococci that are highly resistant to penicillin: increase among neutropenic patients with cancer.
    Carratalá J, Alcaide F, Fernández-Sevilla A, Corbella X, Lińares J, Gudiol F.
    Clin Infect Dis; 1995 May 27; 20(5):1169-73. PubMed ID: 7619995
    [Abstract] [Full Text] [Related]

  • 4. Bacteremic pneumococcal infections in immunocompromised patients without AIDS: the impact of beta-lactam resistance on mortality.
    Fernández Guerrero ML, Ramos JM, Marrero J, Cuenca M, Fernández Roblas R, de Górgolas M.
    Int J Infect Dis; 2003 Mar 27; 7(1):46-52. PubMed ID: 12718810
    [Abstract] [Full Text] [Related]

  • 5. Impact of antibiotic resistance on chemotherapy for pneumococcal infections.
    Pallares R, Viladrich PF, Liñares J, Cabellos C, Gudiol F.
    Microb Drug Resist; 1998 Mar 27; 4(4):339-47. PubMed ID: 9988053
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the response to antimicrobial therapy of penicillin-resistant and penicillin-susceptible pneumococcal disease.
    Friedland IR.
    Pediatr Infect Dis J; 1995 Oct 27; 14(10):885-90. PubMed ID: 8584317
    [Abstract] [Full Text] [Related]

  • 7. Clinical and microbiological epidemiology of Streptococcus pneumoniae bacteremia in cancer patients.
    Garcia-Vidal C, Ardanuy C, Gudiol C, Cuervo G, Calatayud L, Bodro M, Duarte R, Fernández-Sevilla A, Antonio M, Liñares J, Carratalà J.
    J Infect; 2012 Dec 27; 65(6):521-7. PubMed ID: 22954752
    [Abstract] [Full Text] [Related]

  • 8. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci.
    Pallares R, Gudiol F, Liñares J, Ariza J, Rufi G, Murgui L, Dorca J, Viladrich PF.
    N Engl J Med; 1987 Jul 02; 317(1):18-22. PubMed ID: 3587309
    [Abstract] [Full Text] [Related]

  • 9. Pneumococcal bacteremia in hospitalized Israeli adults: epidemiology and resistance to penicillin. Israeli Adult Pneumococcal Bacteremia Group.
    Raz R, Elhanan G, Shimoni Z, Kitzes R, Rudnicki C, Igra Y, Yinnon A.
    Clin Infect Dis; 1997 Jun 02; 24(6):1164-8. PubMed ID: 9195076
    [Abstract] [Full Text] [Related]

  • 10. [Pneumococcal antibiotic resistance].
    Moreillon P, Wenger A, Caldelari I.
    Rev Med Suisse Romande; 2000 Aug 02; 120(8):651-9. PubMed ID: 11028185
    [Abstract] [Full Text] [Related]

  • 11. Streptococcus pneumoniae bacteremia in patients with cancer: disease characteristics and outcomes in the era of escalating drug resistance (1998-2002).
    Kumashi P, Girgawy E, Tarrand JJ, Rolston KV, Raad II, Safdar A.
    Medicine (Baltimore); 2005 Sep 02; 84(5):303-312. PubMed ID: 16148730
    [Abstract] [Full Text] [Related]

  • 12. Community-acquired bacteraemic pneumococcal pneumonia in adults: effect of diminished penicillin susceptibility on clinical outcome.
    Bonnard P, Lescure FX, Douadi Y, Schmit JL, Jounieaux V, Laurans G, Eb F, Ducroix JP.
    J Infect; 2005 Jul 02; 51(1):69-76. PubMed ID: 15979494
    [Abstract] [Full Text] [Related]

  • 13. Influence of penicillin resistance on outcome in adult patients with invasive pneumococcal pneumonia: is penicillin useful against intermediately resistant strains?
    Falcó V, Almirante B, Jordano Q, Calonge L, del Valle O, Pigrau C, Planes AM, Gavaldà J, Pahissa A.
    J Antimicrob Chemother; 2004 Aug 02; 54(2):481-8. PubMed ID: 15215226
    [Abstract] [Full Text] [Related]

  • 14. Penicillin resistance and other predictors of mortality in pneumococcal bacteremia in a population with high human immunodeficiency virus seroprevalence.
    Turett GS, Blum S, Fazal BA, Justman JE, Telzak EE.
    Clin Infect Dis; 1999 Aug 02; 29(2):321-7. PubMed ID: 10476736
    [Abstract] [Full Text] [Related]

  • 15. [Antibiotic resistance in pneumococci].
    Moreillon P, Wenger A.
    Schweiz Med Wochenschr; 1996 Feb 17; 126(7):255-63. PubMed ID: 8720323
    [Abstract] [Full Text] [Related]

  • 16. [beta-lactam-antibiotics in the treatment of community-acquired respiratory tract infections with penicillin-resistant pneumococci].
    Brauers J, Ewig S, Kresken M.
    Pneumologie; 2002 Oct 17; 56(10):605-9. PubMed ID: 12375222
    [Abstract] [Full Text] [Related]

  • 17. Development and validation of a clinical model to predict the presence of β-lactam resistance in viridans group streptococci causing bacteremia in neutropenic cancer patients.
    Shelburne SA, Lasky RE, Sahasrabhojane P, Tarrand JT, Rolston KV.
    Clin Infect Dis; 2014 Jul 15; 59(2):223-30. PubMed ID: 24755857
    [Abstract] [Full Text] [Related]

  • 18. Serious complications of bacteremia caused by Viridans streptococci in neutropenic patients with cancer.
    Marron A, Carratalà J, González-Barca E, Fernández-Sevilla A, Alcaide F, Gudiol F.
    Clin Infect Dis; 2000 Nov 15; 31(5):1126-30. PubMed ID: 11073739
    [Abstract] [Full Text] [Related]

  • 19. Relapsing bacteremia with highly penicillin-resistant pneumococci in a normal host.
    Rivera-Matos IR, Sandigo G, Atkins JT.
    Clin Pediatr (Phila); 1996 Aug 15; 35(8):407-10. PubMed ID: 8862901
    [No Abstract] [Full Text] [Related]

  • 20. Empiric antibiotic protocols for cancer patients with neutropenia: a single-center study of treatment efficacy and mortality in patients with bacteremia.
    Kleinhendler E, Cohen MJ, Moses AE, Paltiel O, Strahilevitz J, Cahan A.
    Int J Antimicrob Agents; 2018 Jan 15; 51(1):71-76. PubMed ID: 28705670
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.